Usefulness of percutaneous transluminal coronary angioplasty after new device coronary interventions

Robert D. Safian, Mark Freed, Anne Lichtenberg, Melissa A. May, Michelle Strzelecki, Cindy L. Grines, Gregory Pavlides, Theodore L. Schreiber, William W. O'Neill

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Percutaneous transluminal coronary angioplasty (PTCA) is often required immediately after laser and atherectomy devices to enlarge lumen dimensions and to salvage device failures. Between January 1989 and June 1992, adjunctive PTCA was applied to 83% of narrowings treated with new interventional devices, including 85% of transluminal extraction atherectomy (n = 290), 72% of high-speed mechanical rotational atherectomy (n = 79), and 89% of excimer laser angioplasty (n = 118) lesions (p = NS). Device success was defined as a decrease in diameter stenosis ≥20%; procedural success was defined as a final diameter stenosis ≤ 50% after PTCA; and salvage PTCA was defined as use of PTCA to manage device-induced vessel occlusion. Although adjunctive PTCA was applied to 487 lesions, it was used to further enlarge the lumen after initial device success in 139 lesions (28.5%). In contrast, adjunctive PTCA was used after initial device failure in 348 lesions (71.5%), including after minimal or no change (decrease in diameter stenosis by 0 to 19%) in diameter stenosis in 244 lesions (50%) and after worsening of diameter stenosis in 104 lesions (21.5%). Salvage PTCA after device-induced vessel occlusion was performed in 61 lesions (12.6%). However, final procedural success after PTCA was achieved in 412 lesions (85%), with a low incidence of Q-wave myocardial infarction (3.5%), emergency bypass surgery (1.8%) and death (2.3%).

Original languageEnglish (US)
Pages (from-to)642-646
Number of pages5
JournalThe American Journal of Cardiology
Volume73
Issue number9
DOIs
StatePublished - Apr 1 1994

Fingerprint

Coronary Balloon Angioplasty
Equipment and Supplies
Pathologic Constriction
Atherectomy
Equipment Failure
Laser Angioplasty
Coronary Atherectomy
Excimer Lasers
Lasers
Emergencies
Myocardial Infarction
Incidence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Safian, R. D., Freed, M., Lichtenberg, A., May, M. A., Strzelecki, M., Grines, C. L., ... O'Neill, W. W. (1994). Usefulness of percutaneous transluminal coronary angioplasty after new device coronary interventions. The American Journal of Cardiology, 73(9), 642-646. https://doi.org/10.1016/0002-9149(94)90926-1

Usefulness of percutaneous transluminal coronary angioplasty after new device coronary interventions. / Safian, Robert D.; Freed, Mark; Lichtenberg, Anne; May, Melissa A.; Strzelecki, Michelle; Grines, Cindy L.; Pavlides, Gregory; Schreiber, Theodore L.; O'Neill, William W.

In: The American Journal of Cardiology, Vol. 73, No. 9, 01.04.1994, p. 642-646.

Research output: Contribution to journalArticle

Safian, RD, Freed, M, Lichtenberg, A, May, MA, Strzelecki, M, Grines, CL, Pavlides, G, Schreiber, TL & O'Neill, WW 1994, 'Usefulness of percutaneous transluminal coronary angioplasty after new device coronary interventions', The American Journal of Cardiology, vol. 73, no. 9, pp. 642-646. https://doi.org/10.1016/0002-9149(94)90926-1
Safian, Robert D. ; Freed, Mark ; Lichtenberg, Anne ; May, Melissa A. ; Strzelecki, Michelle ; Grines, Cindy L. ; Pavlides, Gregory ; Schreiber, Theodore L. ; O'Neill, William W. / Usefulness of percutaneous transluminal coronary angioplasty after new device coronary interventions. In: The American Journal of Cardiology. 1994 ; Vol. 73, No. 9. pp. 642-646.
@article{7320e6b5349d45148bdcf0fdd164cc3d,
title = "Usefulness of percutaneous transluminal coronary angioplasty after new device coronary interventions",
abstract = "Percutaneous transluminal coronary angioplasty (PTCA) is often required immediately after laser and atherectomy devices to enlarge lumen dimensions and to salvage device failures. Between January 1989 and June 1992, adjunctive PTCA was applied to 83{\%} of narrowings treated with new interventional devices, including 85{\%} of transluminal extraction atherectomy (n = 290), 72{\%} of high-speed mechanical rotational atherectomy (n = 79), and 89{\%} of excimer laser angioplasty (n = 118) lesions (p = NS). Device success was defined as a decrease in diameter stenosis ≥20{\%}; procedural success was defined as a final diameter stenosis ≤ 50{\%} after PTCA; and salvage PTCA was defined as use of PTCA to manage device-induced vessel occlusion. Although adjunctive PTCA was applied to 487 lesions, it was used to further enlarge the lumen after initial device success in 139 lesions (28.5{\%}). In contrast, adjunctive PTCA was used after initial device failure in 348 lesions (71.5{\%}), including after minimal or no change (decrease in diameter stenosis by 0 to 19{\%}) in diameter stenosis in 244 lesions (50{\%}) and after worsening of diameter stenosis in 104 lesions (21.5{\%}). Salvage PTCA after device-induced vessel occlusion was performed in 61 lesions (12.6{\%}). However, final procedural success after PTCA was achieved in 412 lesions (85{\%}), with a low incidence of Q-wave myocardial infarction (3.5{\%}), emergency bypass surgery (1.8{\%}) and death (2.3{\%}).",
author = "Safian, {Robert D.} and Mark Freed and Anne Lichtenberg and May, {Melissa A.} and Michelle Strzelecki and Grines, {Cindy L.} and Gregory Pavlides and Schreiber, {Theodore L.} and O'Neill, {William W.}",
year = "1994",
month = "4",
day = "1",
doi = "10.1016/0002-9149(94)90926-1",
language = "English (US)",
volume = "73",
pages = "642--646",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Usefulness of percutaneous transluminal coronary angioplasty after new device coronary interventions

AU - Safian, Robert D.

AU - Freed, Mark

AU - Lichtenberg, Anne

AU - May, Melissa A.

AU - Strzelecki, Michelle

AU - Grines, Cindy L.

AU - Pavlides, Gregory

AU - Schreiber, Theodore L.

AU - O'Neill, William W.

PY - 1994/4/1

Y1 - 1994/4/1

N2 - Percutaneous transluminal coronary angioplasty (PTCA) is often required immediately after laser and atherectomy devices to enlarge lumen dimensions and to salvage device failures. Between January 1989 and June 1992, adjunctive PTCA was applied to 83% of narrowings treated with new interventional devices, including 85% of transluminal extraction atherectomy (n = 290), 72% of high-speed mechanical rotational atherectomy (n = 79), and 89% of excimer laser angioplasty (n = 118) lesions (p = NS). Device success was defined as a decrease in diameter stenosis ≥20%; procedural success was defined as a final diameter stenosis ≤ 50% after PTCA; and salvage PTCA was defined as use of PTCA to manage device-induced vessel occlusion. Although adjunctive PTCA was applied to 487 lesions, it was used to further enlarge the lumen after initial device success in 139 lesions (28.5%). In contrast, adjunctive PTCA was used after initial device failure in 348 lesions (71.5%), including after minimal or no change (decrease in diameter stenosis by 0 to 19%) in diameter stenosis in 244 lesions (50%) and after worsening of diameter stenosis in 104 lesions (21.5%). Salvage PTCA after device-induced vessel occlusion was performed in 61 lesions (12.6%). However, final procedural success after PTCA was achieved in 412 lesions (85%), with a low incidence of Q-wave myocardial infarction (3.5%), emergency bypass surgery (1.8%) and death (2.3%).

AB - Percutaneous transluminal coronary angioplasty (PTCA) is often required immediately after laser and atherectomy devices to enlarge lumen dimensions and to salvage device failures. Between January 1989 and June 1992, adjunctive PTCA was applied to 83% of narrowings treated with new interventional devices, including 85% of transluminal extraction atherectomy (n = 290), 72% of high-speed mechanical rotational atherectomy (n = 79), and 89% of excimer laser angioplasty (n = 118) lesions (p = NS). Device success was defined as a decrease in diameter stenosis ≥20%; procedural success was defined as a final diameter stenosis ≤ 50% after PTCA; and salvage PTCA was defined as use of PTCA to manage device-induced vessel occlusion. Although adjunctive PTCA was applied to 487 lesions, it was used to further enlarge the lumen after initial device success in 139 lesions (28.5%). In contrast, adjunctive PTCA was used after initial device failure in 348 lesions (71.5%), including after minimal or no change (decrease in diameter stenosis by 0 to 19%) in diameter stenosis in 244 lesions (50%) and after worsening of diameter stenosis in 104 lesions (21.5%). Salvage PTCA after device-induced vessel occlusion was performed in 61 lesions (12.6%). However, final procedural success after PTCA was achieved in 412 lesions (85%), with a low incidence of Q-wave myocardial infarction (3.5%), emergency bypass surgery (1.8%) and death (2.3%).

UR - http://www.scopus.com/inward/record.url?scp=0028260042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028260042&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(94)90926-1

DO - 10.1016/0002-9149(94)90926-1

M3 - Article

C2 - 8166058

AN - SCOPUS:0028260042

VL - 73

SP - 642

EP - 646

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 9

ER -